CPR group | CAD group | P value | ||||||
---|---|---|---|---|---|---|---|---|
Group | CEC + EMP | EPC | All | CEC + EMP | EPC | All | ||
Number of patients | n = 40 | n = 15 | n = 55 | n = 30 | n = 9 | n = 39 | ||
Age | (years) | 65.3 ± 2.2 | 66.8 ± 3.1 | 65.7 ± 1.8 | 64.9 ± 2.8 | 67 ± 4.3 | 64.3 ± 2.3 | 0.32/ns |
Gender | Male | 32 (80%) | 10 (67%) | 42 (76%) | 26 (87%) | 6 (67%) | 32 (82%) | 0.63/ns |
Female | 8 (20%) | 5 (33%) | 13 (24%) | 4 (13%) | 3 (33%) | 7 (18%) | ||
Location of CPR | in-hospital | 13 (33%) | 2 (13%) | 15 (27%) | ||||
out-of-hospital | 27 (67%) | 13 (87%) | 40 (73%) | |||||
Duration of CPR | (min) | 27.3 ± 3.5 | 12.3 ± 2 | 23.2 ± 2.7 | ||||
Initial rhythm | VF/VT | 21 (52%) | 11 (73%) | 32 (58%) | ||||
Asystole/PEA | 19 (48%) | 4 (27%) | 23 (42%) | |||||
Cause of cardiac arrest or hospital admission | Cardiac | 29 (72%) | 13 (87%) | 42 (76%) | 30 (100%) | 8 (89%) | 38 (97%) | 0.11/ns |
Non-cardiac | 11 (28%) | 3 (20%) | 14 (24%) | 0 (0%) | 1 (11%) | 1 (3%) | ||
Coronary angiography | 27 (68%) | 14 (93%) | 41 (75%) | 21 (70%) | 6 (66%) | 27 (69%) | 0.62/ns | |
Outcome | Survival <10 days | 21 (52%) | 5 (33%) | 26 (47%) | 0 (0%) | 0 (0%) | 0 (0%) | |
Survival ≥ 10 days | 19 (48%) | 10 (67%) | 29 (53%) | 30 (100%) | 9 (100%) | 39 (100%) | ||
Medication | Vasopressors | 32 (80%) | 15 (100%) | 47 (85%) | 0 (0%) | 0 (0%) | 0 (0%) | |
Statins | 14 (35%) | 1 (7%) | 15 (27%) | 20 (67%) | 3 (33%) | 23 (59%) | <0.05 | |
Consecutive organ failure | Acute heart failure | 10 (25%) | 3 (20%) | 13 (24%) | 0 (0%) | 0 (0%) | 0 (0%) | |
Acute renal failure | 9 (23%) | 1 (7%) | 10 (18%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Acute liver failure | 2 (1%) | 0 (0%) | 2 (4%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Co-morbidities | CAD | 26 (65%) | 14 (93%) | 40 (73%) | 30 (100%) | 7 (77%) | 37 (95%) | 0.09/ns |
PAD | 6 (15%) | 5 (33%) | 11 (20%) | 10 (33%) | 1 (11%) | 11 (28%) | 0.25/ns | |
Congestive heart failure | 6 (15%) | 1 (7%) | 7 (13%) | 6 (20%) | 3 (33%) | 9 (23%) | 0.10/ns | |
Pulmonary disease | 12 (30%) | 3 (20%) | 15 (27%) | 6 (20%) | 4 (44%) | 10 (26%) | 0.89/ns | |
Renal insufficiency | 20 (50%) | 6 (40%) | 26 (47%) | 8 (27%) | 4 (44%) | 12 (31%) | 0.07/ns | |
Liver insufficiency | 7 (18%) | 1 (7%) | 8 (15%) | 3 (10%) | 0 (0%) | 3 (8%) | 0.14/ns | |
Cardiovascular risk factors | Hypertension | 22 (55%) | 4 (27%) | 26 (47%) | 17 (57%) | 4 (44%) | 21 (54%) | 0.49/ns |
Diabetes | 11 (28%) | 5 (33%) | 16 (29%) | 3 (10%) | 1 (11%) | 4 (10%) | <0.05 | |
Hyperlipidemia | 8 (20%) | 1 (7%) | 9 (16%) | 15 (50%) | 2 (22%) | 17 (44%) | <0.01 | |
Smoking | 8 (20%) | 5 (33%) | 13 (24%) | 10 (33%) | 4 (44%) | 14 (36%) | 0.12/ns |